Cat. No.: X23-10-ZQ471
Aurora kinase inhibitor HOI-07, Purity ≥98%
Synonym: 1606160-40-0; HOI-07; (3Z)-3-[(E)-4-(1,3-Benzodioxol-5-yl)-2-oxobut-3-enylidene]-1H-indol-2-one; 2H-Indol-2-one, 3-[4-(1,3-benzodioxol-5-yl)-2-oxo-3-buten-1-ylidene]-1,3-dihydro-; EX-A3650; 3-(4-(Benzo[d][1,3]dioxol-5-yl)-2-oxobut-3-en-1-ylidene)indolin-2-one; Aurora kinase inhibitor
- CAS Number: 1606160-40-0
- Compound CID: 137699283
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Properties
Description
HOI-07 is an Aurora kinase inhibitor that disrupts cell division processes.
Molecular Formula
C19H13NO4
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
HOI-07 can be used for researching the dual inhibitory impact on Aurora kinases and HDACs in cancer treatments.
Related Products
